Phosphoramidite Market Report 2026

Phosphoramidite Market Overview

• Phosphoramidite market size has reached to $1.07 billion in 2025 • Expected to grow to $1.5 billion in 2030 at a compound annual growth rate (CAGR) of 6.9% • Growth Driver: Growth Of The Biopharmaceutical Sector Driving Demand For In DNA And RNA Synthesis • Market Trend: Advancements In Enzymatic DNA Synthesis Through 2025 Funding And Technology Expansion • North America was the largest region in 2025 and Europe is the fastest growing region.

What Is Covered Under Phosphoramidite Market?

Phosphoramidite is a chemical compound commonly used in the synthesis of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) through solid-phase synthesis. It consists of a phosphate group linked to an amine (-NR₂) and is highly reactive, allowing for the stepwise addition of nucleotide bases in oligonucleotide synthesis. Phosphoramidites are crucial in producing synthetic nucleic acids for research, diagnostics, and therapeutic applications. The main types of phosphoramidites are deoxyribonucleic acid (DNA) phosphoramidites, ribonucleic acid (RNA) phosphoramidites, labeled phosphoramidites, modifier phosphoramidites, and others. DNA phosphoramidites are chemical building blocks used in solid-phase DNA synthesis to create custom sequences for applications such as gene synthesis, PCR, and molecular diagnostics. It provides various synthesis methods such as h-phosphonate method, phosphoramidite method, and trivalent phosphorus compounds method for various applications, including gene synthesis, deoxyribonucleic acid (DNA), sequencing, and deoxyribonucleic acid (DNA) amplification. It is used by various end-users, such as academic research, the pharmaceutical industry, and the biotechnology industry.

What Is The Phosphoramidite Market Growth Forecast?

The phosphoramidite market size is expected to see strong growth in the next few years. It will grow to $1.5 billion in 2030 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to expansion of RNA-based therapeutics, growth in gene editing technologies, increased pharmaceutical R&D investment, rising demand for custom oligonucleotides, scaling of automated synthesis platforms. Major trends in the forecast period include rising demand for oligonucleotide synthesis materials, expansion of gene therapy and RNA therapeutics, increasing use in diagnostic and research applications, growing adoption of automated solid-phase synthesis, increased focus on high-purity chemical inputs.

Global Phosphoramidite Market Segmentation

1) By Type: Deoxyribonucleic Acid (DNA) Phosphoramidites, Ribonucleic Acid (RNA) Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites, Other Types 2) By Synthesis Method: H-Phosphonate Method, Phosphoramidite Method, Trivalent Phosphorus Compounds Method 3) By Application: Gene Synthesis, Deoxyribonucleic Acid (DNA) Sequencing, Deoxyribonucleic Acid (DNA) Amplification 4) By End-User: Academic Research, Pharmaceutical Industry, Biotechnology Industry Subsegments: 1) By Deoxyribonucleic Acid (DNA) Phosphoramidites: Standard DNA Phosphoramidites, Degenerate DNA Phosphoramidites, Methylated DNA Phosphoramidites, Backbone-Modified DNA Phosphoramidites 2) By Ribonucleic Acid (RNA) Phosphoramidites: Standard RNA Phosphoramidites, 2'-O-Methyl RNA Phosphoramidites, 2'-Fluoro RNA Phosphoramidites, 2'-O-TBDMS Protected RNA Phosphoramidites 3) By Labeled Phosphoramidites: Fluorescent-Labeled Phosphoramidites, Biotin-Labeled Phosphoramidites, Digoxigenin-Labeled Phosphoramidites, Radioisotope-Labeled Phosphoramidites 4) By Modifier Phosphoramidites: Amine-Modified Phosphoramidites, Thiol-Modified Phosphoramidites, Spacer Phosphoramidites, Azide-Modified Phosphoramidites 5) By Other Types: Chimeric Phosphoramidites, Phosphorothioate Phosphoramidites, PEGylated Phosphoramidites, Photo-Cleavable Phosphoramidites

What Is The Driver Of The Phosphoramidite Market?

The expansion of the biopharmaceutical sector is expected to propel the growth of the phosphoramidite market going forward. The biopharmaceutical sector refers to the industry involved in the research, development, production, and commercialization of biologically derived medical products, including vaccines, gene therapies, monoclonal antibodies, and recombinant proteins. The expansion of the biopharmaceutical sector is due to advancements in biotechnology, the increasing prevalence of chronic diseases, and rising investments in research and development. Biotechnology innovations, such as gene editing and monoclonal antibody therapies, have created more effective and targeted treatments. For instance, in October 2025, Office for National statistics, a UK-based government department, reported that in 2024, UK life sciences industry comprised 6,170 businesses operating across 7,320 sites, employing 359,600 people and generating $191 billion (£146.9 billion) in turnover. The largest subsector by both company count and workforce was medical technology, representing 60% of all companies and 55% of total employment. Therefore, the expansion of the biopharmaceutical sector is driving the growth of the phosphoramidite industry.

Key Players In The Global Phosphoramidite Market

Major companies operating in the phosphoramidite market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., Aragen Life Sciences, Twist Bioscience, Innovassynth Technologies (I) Ltd., Tokyo Chemical Industry Co. Ltd. (TCI), Aurigene Services, Eurofins Genomics, LGC Biosearch Technologies, Link Technologies Ltd., Creative Biolabs, Biosynth Carbosynth, TriLink BioTechnologies, ChemGenes Corporation, Berry & Associates Inc., Lumiprobe Corporation, Hongene Biotech Corporation, Carbolink India Pvt. Ltd., PolyOrg Inc., Glen Research, Gene Link Inc., emp BIOTECH GmbH

Global Phosphoramidite Market Trends and Insights

Major companies operating in the phosphoramidite market are focusing on developing advanced DNA synthesis, such as convertible-preferred stock financing round to enhance the adoption and development of Gibson SOLA technology for rapid DNA and mRNA synthesis. Convertible-preferred stock financing refers to a method of raising capital in which a company issues preferred shares that can later be converted into a predetermined number of common shares. For instance, in March 2025, Telesis Bio Inc., a US-based biotechnology company, announced securing up to $21 million in new financing to accelerate the commercialization of its next-generation enzymatic DNA synthesis platform, Gibson SOLA, with support from several strategic investors. This funding aims to scale the company’s fully enzymatic DNA synthesis technology, expand its R&D and manufacturing capabilities, and broaden access to rapid, customizable long-DNA production. The company utilizes a proprietary enzymatic approach that enables fast and precise synthesis of long DNA sequences, addressing current bottlenecks associated with traditional phosphoramidite-based methods.

What Are Latest Mergers And Acquisitions In The Phosphoramidite Market?

In May 2023, Actylis, a US-based chemicals and raw materials company, partnered with Innovassynth India to address nucleic acid supply chain vulnerabilities. With this partnership, Innovassynth and Actylis will strengthen the phosphoramidite market by ensuring a stable, transparent, and diversified supply chain, expanding global access to high-quality nucleosides and phosphoramidites for pharmaceutical and biotech applications. Innovassynth India is an India-based manufacturer of protected nucleosides, phosphoramidites, and reagents.

Regional Insights

North America was the largest region in the phosphoramidite market in 2025. Europe is expected to be the fastest-growing region during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Phosphoramidite Market?

The phosphoramidite market consists of sales of spacer and linker phosphoramidites, fluorescent dye-Labeled phosphoramidites, biotinylated phosphoramidites, and structural phosphoramidites. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Phosphoramidite Market Report 2026?

The phosphoramidite market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the phosphoramidite industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.